Molina Healthcare, Inc. (MOH)
USD 296.59
(1.65%)
USD 296.59
(1.65%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.09 Billion USD | 37.75% |
| 2022 | 792 Million USD | 20.18% |
| 2021 | 659 Million USD | -2.08% |
| 2020 | 673 Million USD | -8.68% |
| 2019 | 737 Million USD | 4.24% |
| 2018 | 707 Million USD | 238.09% |
| 2017 | -512 Million USD | -6500.0% |
| 2016 | 8 Million USD | -94.41% |
| 2015 | 143 Million USD | 129.82% |
| 2014 | 62.22 Million USD | 17.56% |
| 2013 | 52.92 Million USD | 440.64% |
| 2012 | 9.79 Million USD | -52.97% |
| 2011 | 20.81 Million USD | -62.13% |
| 2010 | 54.97 Million USD | 78.08% |
| 2009 | 30.86 Million USD | -50.53% |
| 2008 | 62.39 Million USD | 6.97% |
| 2007 | 58.33 Million USD | 27.56% |
| 2006 | 45.72 Million USD | 65.7% |
| 2005 | 27.59 Million USD | -50.52% |
| 2004 | 55.77 Million USD | 31.18% |
| 2003 | 42.51 Million USD | 39.36% |
| 2002 | 30.5 Million USD | 1.26% |
| 2001 | 30.12 Million USD | 101.34% |
| 2000 | 14.96 Million USD | 58.3% |
| 1999 | 9.45 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 301 Million USD | 39.35% |
| 2024 Q2 | 301 Million USD | 0.0% |
| 2024 Q3 | 326 Million USD | 8.31% |
| 2023 Q3 | 245 Million USD | -20.71% |
| 2023 Q4 | 216 Million USD | -11.84% |
| 2023 Q1 | 321 Million USD | 473.21% |
| 2023 Q2 | 309 Million USD | -3.74% |
| 2023 FY | 1.09 Billion USD | 37.75% |
| 2022 Q1 | 258 Million USD | 150.49% |
| 2022 Q3 | 230 Million USD | -7.26% |
| 2022 Q4 | 56 Million USD | -75.65% |
| 2022 FY | 792 Million USD | 20.18% |
| 2022 Q2 | 248 Million USD | -3.88% |
| 2021 Q4 | 103 Million USD | -27.97% |
| 2021 Q1 | 228 Million USD | 570.59% |
| 2021 FY | 659 Million USD | -2.08% |
| 2021 Q2 | 185 Million USD | -18.86% |
| 2021 Q3 | 143 Million USD | -22.7% |
| 2020 Q2 | 276 Million USD | 55.06% |
| 2020 FY | 673 Million USD | -8.68% |
| 2020 Q1 | 178 Million USD | 5.95% |
| 2020 Q4 | 34 Million USD | -81.62% |
| 2020 Q3 | 185 Million USD | -32.97% |
| 2019 FY | 737 Million USD | 4.24% |
| 2019 Q1 | 198 Million USD | -1.49% |
| 2019 Q2 | 196 Million USD | -1.01% |
| 2019 Q4 | 168 Million USD | -4.0% |
| 2019 Q3 | 175 Million USD | -10.71% |
| 2018 FY | 707 Million USD | 238.09% |
| 2018 Q4 | 201 Million USD | 2.03% |
| 2018 Q2 | 202 Million USD | 88.79% |
| 2018 Q1 | 107 Million USD | 140.84% |
| 2018 Q3 | 197 Million USD | -2.48% |
| 2017 Q2 | -230 Million USD | -398.7% |
| 2017 Q1 | 77 Million USD | 184.62% |
| 2017 FY | -512 Million USD | -6500.0% |
| 2017 Q3 | -97 Million USD | 57.83% |
| 2017 Q4 | -262 Million USD | -170.1% |
| 2016 Q1 | 24 Million USD | -18.93% |
| 2016 Q3 | 42 Million USD | 27.27% |
| 2016 Q4 | -91 Million USD | -316.67% |
| 2016 Q2 | 33 Million USD | 37.5% |
| 2016 FY | 8 Million USD | -94.41% |
| 2015 Q2 | 39 Million USD | 39.29% |
| 2015 Q4 | 29.6 Million USD | -35.64% |
| 2015 Q3 | 46 Million USD | 17.95% |
| 2015 Q1 | 28 Million USD | -17.14% |
| 2015 FY | 143 Million USD | 129.82% |
| 2014 FY | 62.22 Million USD | 17.56% |
| 2014 Q4 | 33.79 Million USD | 109.6% |
| 2014 Q3 | 16.12 Million USD | 106.4% |
| 2014 Q2 | 7.81 Million USD | 73.65% |
| 2014 Q1 | 4.49 Million USD | 149.29% |
| 2013 Q4 | -9.12 Million USD | -220.57% |
| 2013 Q2 | 24.57 Million USD | -17.86% |
| 2013 Q3 | 7.56 Million USD | -69.2% |
| 2013 Q1 | 29.91 Million USD | 16.66% |
| 2013 FY | 52.92 Million USD | 440.64% |
| 2012 Q3 | 3.36 Million USD | 109.02% |
| 2012 Q4 | 25.64 Million USD | 662.28% |
| 2012 Q2 | -37.3 Million USD | -306.24% |
| 2012 Q1 | 18.08 Million USD | 154.88% |
| 2012 FY | 9.79 Million USD | -52.97% |
| 2011 Q2 | 17.44 Million USD | 0.3% |
| 2011 FY | 20.81 Million USD | -62.13% |
| 2011 Q4 | -32.96 Million USD | -273.93% |
| 2011 Q3 | 18.95 Million USD | 8.66% |
| 2011 Q1 | 17.38 Million USD | -1.36% |
| 2010 FY | 54.97 Million USD | 78.08% |
| 2010 Q2 | 10.57 Million USD | -0.1% |
| 2010 Q1 | 10.59 Million USD | 336.81% |
| 2010 Q3 | 16.17 Million USD | 52.88% |
| 2010 Q4 | 17.62 Million USD | 9.0% |
| 2009 FY | 30.86 Million USD | -50.53% |
| 2009 Q1 | 12.21 Million USD | -21.43% |
| 2009 Q2 | 14.56 Million USD | 19.28% |
| 2009 Q3 | 8.56 Million USD | -41.2% |
| 2009 Q4 | -4.47 Million USD | -152.22% |
| 2008 Q2 | 15.82 Million USD | 26.84% |
| 2008 Q1 | 12.47 Million USD | -30.35% |
| 2008 FY | 62.39 Million USD | 6.97% |
| 2008 Q4 | 15.54 Million USD | -5.7% |
| 2008 Q3 | 16.48 Million USD | 4.15% |
| 2007 FY | 58.33 Million USD | 27.56% |
| 2007 Q3 | 17.51 Million USD | 31.54% |
| 2007 Q2 | 13.31 Million USD | 38.8% |
| 2007 Q1 | 9.59 Million USD | -17.62% |
| 2007 Q4 | 17.91 Million USD | 2.27% |
| 2006 Q1 | 8.59 Million USD | -19.96% |
| 2006 Q3 | 12.34 Million USD | -6.17% |
| 2006 Q4 | 11.64 Million USD | -5.65% |
| 2006 FY | 45.72 Million USD | 65.7% |
| 2006 Q2 | 13.15 Million USD | 53.11% |
| 2005 FY | 27.59 Million USD | -50.52% |
| 2005 Q2 | -4.7 Million USD | -131.89% |
| 2005 Q1 | 14.75 Million USD | -9.38% |
| 2005 Q4 | 10.73 Million USD | 57.57% |
| 2005 Q3 | 6.81 Million USD | 244.73% |
| 2004 Q3 | 16.43 Million USD | 37.56% |
| 2004 Q4 | 16.28 Million USD | -0.93% |
| 2004 FY | 55.77 Million USD | 31.18% |
| 2004 Q2 | 11.95 Million USD | 7.68% |
| 2004 Q1 | 11.09 Million USD | -6.47% |
| 2003 Q1 | 7.98 Million USD | 0.0% |
| 2003 FY | 42.51 Million USD | 39.36% |
| 2003 Q4 | 11.86 Million USD | 1.21% |
| 2003 Q3 | 11.72 Million USD | 7.1% |
| 2003 Q2 | 10.94 Million USD | 37.18% |
| 2002 FY | 30.5 Million USD | 1.26% |
| 2001 FY | 30.12 Million USD | 101.34% |
| 2000 FY | 14.96 Million USD | 58.3% |
| 1999 FY | 9.45 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Cigna Corporation | 5.16 Billion USD | 78.873% |
| Centene Corporation | 2.7 Billion USD | 59.623% |
| CVS Health Corporation | 8.34 Billion USD | 86.925% |
| Elevance Health Inc. | 5.98 Billion USD | 81.777% |
| Humana Inc. | 2.48 Billion USD | 56.167% |
| Oscar Health, Inc. | -270.72 Million USD | 502.988% |
| UnitedHealth Group Incorporated | 22.38 Billion USD | 95.125% |